Blockstream’s Bitcoin Mining Security Token Projected to Outperform Direct Bitcoin Investments
6.9.2024 07:00:00 CEST | Business Wire | Press release
Blockstream Mining Note 2 (BMN2) Series 3 is Open with a 4-Year Fixed Cost of $31,000 PH/s.The Most Cost-Effective, Effortless Way for Eligible Investors to Actively Participate in Proof-of-Work Rewards.
Blockstream, the global leader in Bitcoin infrastructure technology, has launched series 3 of its highly anticipated Blockstream Mining Note 2 (BMN2), responding once again to heightened investor interest in Bitcoin mining opportunities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905372943/en/
(Graphic: Business Wire)
BMN2, an EU-compliant hash rate-backed security token, provides direct exposure to Bitcoin hash rate operated by Blockstream’s state-of-the-art, enterprise-grade mining facilities across North America. BMN2 is designed to replicate the first iteration of the Blockstream Mining Note (BMN1), which launched in 2021 and matured in July this year, delivering a 32% bitcoin return over its 3-year term. Arnab Naskar, Co-founder and Co-CEO of STOKR, a digital asset investment platform, declares it “the highest payout in real world asset (RWA) security token history.”
The Bitcoin industry has matured greatly since the launch of BMN1 in 2021. Bitcoin mining-adjacent investment products, such as hash rate contracts and hosted mining services, have become available to investors and businesses. However, these products and services lack investment conveniences — secondary market liquidity, long-term fixed rates, instant exposure, and market timing protection — freedoms that BMN2 provides.
BMN2—the primary offering of which went live on July 18, 2024 raising just under $7M—follows a similar economic model to BMN1, offering a highly competitive hash price for investors and an investment opportunity that can outpace bitcoin purchases on the spot market. Further, BMN2 includes hash rate safeguards that exceed that of its predecessor, including a reserve of 50% of the stated hash rate (1PH/s per day) to protect against potential miner failures, reduced efficiency, and other non-force majeure issues.
Available to qualified, non-US investors via Luxembourg-based virtual assets service provider, STOKR, BMN2 is offered at a set, discounted hash price of $21.23 for 48 months. Bitcoin hash price refers to the short-term profitability of bitcoin mining and measures the revenue that Bitcoin miners can earn. The BMN2 is prominently priced well below the current spot market hash price to incentivize bitcoin holders, investors, and businesses to directly partake in maintaining the Bitcoin network. Each BMN2 security token entitles holders to the bitcoin produced by 1 PH/s (petahash per second) of Blockstream’s mining hash rate, ensuring a consistent stream of bitcoin rewards directly linked to mining performance. BMN2 provides a well-timed onramp for investors to strategically take part in the market before the next bitcoin halving.
Bitcoin mining operations for BMN2 commenced this week at an equivalent hosting rate less than $.045 kWh (kilowatt-hour), which is substantially lower than the industry average of $.065 for enterprises, and $.075 commonly available for retail customers. The strength, reliability, and performance of Blockstream’s advanced mining fleet allows for the extension of favorable terms to the greater Bitcoin community to contribute to the network’s decentralization. Additionally, over 80% of BMN2 power is derived from carbon neutral sources—wind, solar, and nuclear—making it a conscientious investment opportunity that aligns investor interests, community collaboration, and offers an attractive entry point relative to the historical hash price market.
“Operational excellence and integrity are at the core of our mining business,” said Chris Cook, CIO of Blockstream. “We know first-hand the complexities involved in mining Bitcoin—hardware challenges, energy curtailment, and price fluctuation, to name a few. We created the BMN product to deliver a consistent hash rate with the goal of maintaining a strong and steady investment outcome.”
Blockstream’s leadership in Bitcoin mining is well-established. It traces its roots back to CEO and Co-founder Dr. Adam Back’s invention of the HashCash algorithm behind the proof-of-work protocol, a fundamental component of Bitcoin’s security architecture. Dr. Back’s pioneering work laid the groundwork for Bitcoin, and his ongoing contributions with the BMN and BASIC note, another Blockstream mining offering, to continue to shape the future of the entire real world asset industry.
For access to the BMN2 security token offering and regular updates, eligible investors can register at https://stokr.io/featured-assets/blockstream-mining2.
About Blockstream Mining
Founded in 2014, Blockstream is the global leader in Bitcoin and blockchain infrastructure. Blockstream Mining offers turnkey Bitcoin mining services and solutions designed to provide institutions full transparency and control over their mining operations. By providing secure state-of-the art facilities for a reliable miner colocation, coupled with exceptional technical talent infrastructure, Blockstream Mining purpose-built data centers meet the strict physical and network security requirements of global institutional and enterprise customers. Keeping mining carbon emissions to a minimum, current mining sites are located in the US and Canada, using a majority of non-fossil power sources.
About STOKR
STOKR is at the forefront of transforming financial assets for the digital era. As a leading digital investment platform, STOKR helps asset managers, fund managers, and issuers to tokenize and manage a diverse range of financial assets. STOKR’s platform simplifies the entry into the world of digital securities with a comprehensive suite of services that includes dedicated investment structures, state-of-the-art technology infrastructure, and full-scale support in payments and compliance.
With STOKR, clients can effortlessly issue digital securities and foster strong investor relationships, benefiting from enhanced liquidity thanks to the integration with secondary markets. STOKR’s approach removes the technical complexities typically associated with digital securities, offering a seamless investment experience. Leveraging over six years of innovation and expertise in the digital securities market, STOKR provides a sophisticated and secure environment for capital raising.
Registered as a Virtual Assets Service Provider (VASP) with the CSSF in Luxembourg, STOKR is committed to the highest standards of regulatory compliance, ensuring a reliable and trustworthy platform for all stakeholders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905372943/en/
Contacts
Sarah L. Macedonio
Sarah L. Macedonio
sarah@mining.blockstream.com
(860) 573-9580
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom